For more information on the new features, see the New features page.
This item is authorised by the following title:
For transitional provisions relating to the repeal of this standard, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—October 2023) Instrument 2023.
For transitional provisions relating to the repeal of this standard, see subsections 4(2) and (3) of the Therapeutic Goods (Poisons Standard—October 2023) Instrument 2023.